A detailed history of Advisor Partners Ii, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Advisor Partners Ii, LLC holds 108,039 shares of NVO stock, worth $11.4 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
108,039
Previous 44,870 140.78%
Holding current value
$11.4 Million
Previous $7.26 Million 35.31%
% of portfolio
0.4%
Previous 0.34%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$90.94 - $199.54 $5.74 Million - $12.6 Million
63,169 Added 140.78%
108,039 $9.83 Million
Q2 2023

Aug 10, 2023

BUY
$155.98 - $172.65 $841,668 - $931,619
5,396 Added 13.67%
44,870 $7.26 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $533,462 - $641,493
4,031 Added 11.37%
39,474 $6.28 Million
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $513,980 - $678,273
5,012 Added 16.47%
35,443 $4.8 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $2.9 Million - $3.56 Million
30,431 New
30,431 $3.03 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Advisor Partners Ii, LLC Portfolio

Follow Advisor Partners Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Partners Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Partners Ii, LLC with notifications on news.